The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 22

More JCP Articles

JCP
Effect of Zuranolone vs Placebo in MDD
Original Research

February 20, 2023

This phase 3 RCT found significant improvement in depressive symptoms with zuranolone beginning at day 3 of treatment.
, , , et al
JCP
Long-Term Suicidal Ideation Profiles in Late-Life Depression
Original Research

February 15, 2023

Suicidal ideation predicts suicide attempts in young and middle-aged persons, but its predictive power in late life remains unclear. This study aimed to identify ideation profiles in depressed older…
, , , et al
JCP
Predictors for Initiation of LAIs in Individuals With Early-Phase Schizophrenia
Original Research

February 13, 2023

Initiation of LAIs was predicted by greater switching of oral antipsychotics and more ED visits. LAIs are often used to respond to relapse rather than prevent it.
, , , et al
JCP
Antipsychotic Dose and Weight Gain
Meta-Analysis

February 8, 2023

Although effects on weight gain have been explored for several antipsychotics, the role of dose in producing these effects has not been widely studied. This meta-analysis examined the association…
, , , et al
JCP
Skeletal and Dental Fractures Associated With ECT
Clinical and Practical Psychopharmacology

February 6, 2023

Recent data suggest the risk of skeletal or dental fracture with ECT may be as low as 0.36 events per 100,000 ECTs.
JCP
Combining Ketamine and Psychotherapy for PTSD: A Systematic Review and Meta-Analysis
Brief Report

February 6, 2023

Ketamine plus psychotherapy may be both highly effective and feasible, based on the findings of 4 recent studies.
, , , et al
JCP
Safety and Tolerability of Concomitant Intranasal Esketamine and MAOI Treatment
Case Report

February 1, 2023

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in some patients.
, , , et al
JCP
Ketamine vs Esketamine for TRD
Original Research

February 1, 2023

Are ketamine and esketamine equally efficacious? This observational study compares the efficacy of subanesthetic intravenous ketamine with that of intranasal esketamine for treatment-resistant depression in a real-world clinical setting.
, , , et al
JCP
Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression
Original Research

January 30, 2023

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived functional health in patients with PPD.
, , , et al
JCP
Prolactin, Antipsychotics, and Fracture Risk
Clinical and Practical Psychopharmacology

January 30, 2023

Fracture risk associated with antipsychotics may be related to whether they increase prolactin. If long-term treatment with prolactin-raising agents is necessary, prolactin levels should be regularly monitored.
JCP
Young-Adult Social Outcomes of ADHD
Original Research

January 25, 2023

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional support.
, , , et al
JCP
Effects of ECT in Comorbid Depression and Dementia
Original Research

January 25, 2023

Limited data suggest a role for electroconvulsive therapy (ECT) in treating behavioral and psychological symptoms of dementia. Using a larger sample size than in previous reports, this study examined…
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe